Joint regeneration Surprise: understand the soreness first

What to notice before changing anything

If you can, put one finger near the sore spot. Then notice which motion first causes the ache. Stairs or sitting may bring out a knee ache. A hip can feel stiff during your first steps. Reaching high or behind you may make a shoulder ache. Don't overlook swelling, warmth, weakness or lost sleep. Write down the day the soreness began.

These details direct the exam toward the sore area and painful motion.

What to try when the soreness is mild

Ease back on any movement that makes the soreness rise sharply. Stop before the motion becomes uncomfortable, since long rest can add stiffness. Heat may loosen the joint before you move. Cold doesn't help everyone, but it may settle soreness afterward. Walking may feel steadier with a brace or cane. Ask your doctor or pharmacist before adding medicine.

If the ache isn't easing, arrange an exam instead of guessing longer.

When to arrange a closer look

Have the joint checked if the ache often returns or blocks daily tasks. Seek quick help when heat and swelling come with fever. Don't wait if weakness begins suddenly or you cannot put weight on the joint. At a regular visit, the clinician asks when the ache began. A hands-on exam checks movement, strength, swelling and sore spots. Take older x-rays and write down your medicines.

QC Kinetix offers regenerative treatments, in which a clinician gathers parts of your blood or marrow fluid and places them at the sore joint.

Sources

1. The RESTORE trial - a participant-, injector- and assessor-blinded RCT of 288 adults aged 50+ with symptomatic medial knee OA (Kellgren-Lawrence 2-3) - compared three weekly intra-articular PRP injections against saline placebo, with co-primary endpoints of 12-month knee pain and medial tibial cartilage volume on MRI. PRP did not beat placebo on either. It is the single best-designed test of the specific claim that PRP changes joint structure, and it was negative.

   Bennell KL, et al. — Effect of Intra-articular Platelet-Rich Plasma vs Placebo Injection on Pain and Medial Tibial Cartilage Volume in Patients With Knee Osteoarthritis: The RESTORE Randomized Clinical Trial.. JAMA, 2021. DOI: 10.1001/jama.2021.19415.

2. A randomized controlled study of 111 patients aged 18-65 with hip osteoarthritis compared three weekly ultrasound-guided injections of PRP, hyaluronic acid, or both. PRP had the lowest VAS at every follow-up and beat HA significantly at 6 months (mean VAS 21 vs 44). But the WOMAC advantage present at 2 and 6 months was NO LONGER significant at 12 months, and the combination arm did worse than PRP alone.

   Dallari D, et al. — Ultrasound-Guided Injection of Platelet-Rich Plasma and Hyaluronic Acid, Separately and in Combination, for Hip Osteoarthritis: A Randomized Controlled Study.. The American journal of sports medicine, 2016. DOI: 10.1177/0363546515620383.

3. The PRIMA trial randomized 100 patients with ankle osteoarthritis to two ultrasound-guided intra-articular PRP injections or saline placebo. AOFAS scores improved 10 points with PRP (63 to 73) and 11 points with placebo (64 to 75); the adjusted between-group difference over 26 weeks was -1 (95% CI -6 to 3, p=0.56). The authors state the results do not support using PRP for ankle osteoarthritis. The evidence for a biologic in one joint does not transfer to another.

   Paget LDA, et al. — Effect of Platelet-Rich Plasma Injections vs Placebo on Ankle Symptoms and Function in Patients With Ankle Osteoarthritis: A Randomized Clinical Trial.. JAMA, 2021. DOI: 10.1001/jama.2021.16602.

4. A systematic review and meta-analysis of randomized trials found that augmenting arthroscopic rotator cuff repair with platelet-rich plasma reduces the retear rate and improves clinical function scores, whereas platelet-rich FIBRIN gives no clinically meaningful benefit - with the authors cautioning about the small number and heterogeneity of studies. The shoulder's best biologic evidence is for PRP used ALONGSIDE a repair operation, not as a substitute for one.

   Peng Y, et al. — Efficacy of platelet-rich plasma and platelet-rich fibrin in arthroscopic rotator cuff repair: A systematic review and meta-analysis.. PM & R : the journal of injury, function, and rehabilitation, 2023. DOI: 10.1002/pmrj.13049.

5. A pairwise and network meta-analysis of 18 randomized trials in rotator cuff TENDINOPATHY found corticosteroid helps at 3-6 weeks but not beyond 24 weeks, while PRP and prolotherapy may yield better outcomes in the long term (over 24 weeks) - with the authors warning that heterogeneity requires cautious interpretation. Tendon and joint-surface problems do not behave the same way, and a shoulder page should not borrow knee-OA evidence.

   Lin MT, et al. — Comparative Effectiveness of Injection Therapies in Rotator Cuff Tendinopathy: A Systematic Review, Pairwise and Network Meta-analysis of Randomized Controlled Trials.. Archives of physical medicine and rehabilitation, 2019. DOI: 10.1016/j.apmr.2018.06.028.

6. The evidence overview underpinning the 2020 EULAR recommendations on intra-articular therapies pooled 29 quality-appraised systematic reviews. Hyaluronic acid showed a small effect on pain and function in KNEE OA but not in hip OA or shoulder capsulitis; intra-articular glucocorticoid showed small effects in knee OA and on function in hip OA and shoulder capsulitis; PRP showed benefit in knee OA but NOT in hip OA, and mesenchymal stem cells behaved similarly. Overall conclusion: most intra-articular therapies exert SMALL effects and are well tolerated.

   Rodriguez-García SC, et al. — Efficacy and safety of intra-articular therapies in rheumatic and musculoskeletal diseases: an overview of systematic reviews.. RMD open, 2021. DOI: 10.1136/rmdopen-2021-001658.

7. The lifetime risk of developing symptomatic knee osteoarthritis is approximately 45%, rising with obesity and with a history of significant knee injury. Almost half of all adults will eventually face the decisions this topic describes.

   Murphy L, et al. — Lifetime risk of symptomatic knee osteoarthritis.. Arthritis and rheumatism, 2008. DOI: 10.1002/art.24021.